Qube Research & Technologies Ltd - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 82 filers reported holding SURFACE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q3 2022$32,000
-40.7%
30,311
-8.5%
0.00%
Q2 2022$54,000
-55.4%
33,143
+30.6%
0.00%
-100.0%
Q4 2021$121,000
+49.4%
25,371
+133.5%
0.00%0.0%
Q2 2021$81,000
-77.7%
10,864
-76.7%
0.00%
-83.3%
Q1 2021$364,000
-67.5%
46,615
-61.5%
0.01%
-62.5%
Q4 2020$1,119,000
+75.7%
121,144
+31.2%
0.02%
+77.8%
Q3 2020$637,000
+537.0%
92,332
+506.6%
0.01%
+800.0%
Q2 2020$100,00015,2220.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$22,297,0007.41%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,291,0000.67%
SummerHaven Investment Management, LLC 128,078$970,0000.57%
Parkman Healthcare Partners LLC 248,267$1,879,0000.48%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$379,0000.21%
C M BIDWELL & ASSOCIATES LTD 33,030$250,0000.17%
ARK Investment Management 4,618,354$34,961,0000.08%
Knights of Columbus Asset Advisors LLC 114,594$867,0000.08%
Orbimed Advisors 909,666$6,886,0000.08%
HighVista Strategies LLC 13,932$105,0000.07%
View complete list of SURFACE ONCOLOGY INC shareholders